A phase IB clinical trial of 15 Gy HDR brachytherapy followed by hypofractionated/SBRT in the management of intermediate-risk prostate cancer.
暂无分享,去创建一个
B. Leiby | A. Dicker | R. Den | C. Lallas | E. Trabulsi | M. Hurwitz | L. Gomella | A. Harrison | C. Peng | L. Doyle | N. Williams | Jacob Greenspan